搜索结果:'Modified Peptide'
| 货号 | 产品名称 | 靶点 | 纯度 | 化学结构 |
|---|---|---|---|---|
| GC17195 | Bax inhibitor peptide V5 | — |
|
|
|
A Bax inhibitor
|
||||
| GC49883 | DAPK Substrate Peptide (trifluoroacetate salt) | — |
|
|
|
A DAPK1 peptide substrate
|
||||
| GC17650 | DAPK Substrate Peptide | — |
|
|
|
A DAPK1 peptide substrate
|
||||
| GC16695 | Bax inhibitor peptide, negative control | — |
|
|
|
Peptide inhibit Bax translocation to mitochondria
|
||||
| GC16023 | Bax inhibitor peptide P5 | — |
|
|
|
Bax inhibitor
|
||||
| GC52364 | Vimentin (139-159)-biotin Peptide | — |
|
|
|
A biotinylated vimentin peptide
|
||||
| GC52371 | Vimentin (G146R) (139-159)-biotin Peptide | — |
|
|
|
A biotinylated mutant vimentin peptide
|
||||
| GC36151 | Glucagon-Like Peptide (GLP) II, human | — |
|
|
|
Glucagon-Like Peptide (GLP) II, human 是由原胰高血糖素 C 端衍生的33 氨基酸肽，主要由肠道L细胞产生。Glucagon-Like Peptide (GLP) II 可刺激肠粘膜生长，减少肠细胞的凋亡。
|
||||
| GC52196 | RGD Peptide | — |
|
|
|
An inhibitor of integrin-ligand interactions
|
||||
| GC37524 | RGD peptide (GRGDNP) TFA | — |
|
|
|
An inhibitor of integrin-
|
||||
| GC52476 | Bax Inhibitor Peptide V5 (trifluoroacetate salt) | — |
|
|
|
A Bax inhibitor
|
||||
| GC52370 | Citrullinated Vimentin (R144) (139-159)-biotin Peptide | — |
|
|
|
A biotinylated and citrullinated vimentin peptide
|
||||